The size of the Protein Expression Market in North America was worth USD 790 Million in 2019 and estimated to be growing at a CAGR of 7.36%, to reach USD 970 Million by 2024.
Protein expression is the process of altering, synthesizing and controlling the proteins in living organisms.Proteins are controlled and manufactured depending upon the practical need in the host cell. Biotechnology based companies are creating novel therapeutics with negligible side effects and thereby generating a huge market for Protein expression.
The growth of the North America Protein Expression market is majorly driven by factors such as rise in the R&D movement in the pharma division, prospects in the field of proteomics, rising incidences of chronic diseases, and initiatives taken by the governments. Growth in the biologics market will also boost the market growth. However, issues such as high product development costs and complex Regulatory Environment are restraining the growth of the market.
This research report segmented and sub-segmented into the following categories:
The USA leads the market in this region with a share of around 70% of the regional market.
Companies playing a dominant role in the North America Protein Expression Market profiled in this report are Agilent Technologies, Life Technologies Corporation, Bio-Rad Laboratories, New England BioLabs, Merck Millipore, Takara Bio, Thermo Fisher Scientific, and Promega Corporation.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Expression System
5.1.1 Yeast Expression
5.1.2 Insect Expression
5.1.3 Cell-Free Expression
5.1.4 Bacterial Expression
5.1.5 Algal Expression
5.1.6 Mammalian Expression
5.2 By Product
5.2.1 Reagents
5.2.2 Services
5.2.3 Instruments
5.2.4 Others
5.3 By Application
5.3.1 Industrial Proteins
5.3.2 Cell Culture
5.3.3 Research
5.3.4 Therapeutic Proteins
5.3.5 Transfection technologies
5.3.6 Others
5.4 By End User
5.4.1 Biotechnology
5.4.2 Pharmaceutics
5.4.3 Academia
6. Geographical Analysis
6.1 Introduction
6.2 United States
6.3 Canada
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Agilent Technologies
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Life Technologies Corporation
8.3 Bio-Rad Laboratories
8.4 New England BioLabs
8.5 Merck Millipore
8.6 Takara Bio
8.7 Thermo Fisher Scientific
8.8 Promega Corporation
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
